Pharma Journalist -

REGENXBIO Inc. has received a setback in its efforts to bring a gene therapy to patients with Hunter syndrome, after the U.S. Food and Drug Administration (FDA) issued a Complete…
Read More...

Biocodex and THX Pharma (Theranexus) have entered a strategic licensing agreement aimed at advancing treatments for three rare and serious genetic disorders, marking a significant…
Read More...

As Medical Affairs continues to evolve into a strategic cornerstone of the biopharma industry, the ability to clearly define, measure, and communicate impact has never been more…
Read More...

Everest Medicines has entered an exclusive licensing agreement with Shaanxi Micot Pharmaceutical Technology to commercialize the experimental therapy MT1013 across China and the…
Read More...

Eisai Co., Ltd. and Shanghai Henlius Biotech have signed an exclusive commercialization and co-exclusive development and manufacturing licensing agreement for the anti-PD-1 antibody…
Read More...

Grünenthal and Apotex Inc. have announced a new licensing agreement granting Apotex exclusive rights in Canada to Nebido (testosterone undecanoate), a long-acting injectable therapy…
Read More...

PrimeGen US, a biotechnology company focused on regenerative medicine, has agreed to merge with special purpose acquisition company DT Cloud Star Acquisition Corporation in a…
Read More...

The Coalition for Epidemic Preparedness Innovations (CEPI) has partnered with contract development and manufacturing organization Samsung Biologics to strengthen global readiness for…
Read More...

Relay Therapeutics has received Breakthrough Therapy designation from the U.S. Food and Drug Administration for its investigational drug zovegalisib in combination with fulvestrant for…
Read More...

Aquestive Therapeutics said the U.S. Food and Drug Administration has issued a Complete Response Letter (CRL) for its New Drug Application seeking approval of Anaphylm, an…
Read More...